6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
29m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
29m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
53m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
53m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
53m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Fortress Biotech Inc (NASDAQ:FBIO) — investor relations, events, news, and company updates on 6ix.

Latest News

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

Financials

Revenue

$63.26 M

Market Cap

$81.55 M

EPS

-0.07

Community Chat

Ask AI